Moloney Securities Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Moloney Securities Asset Management's ELV Position: Q3 2025 in Review
Moloney Securities Asset Management reduced its Elevance Health (ELV) stake by 1.5% in Q3 2025, selling an estimated $6.84K and leaving 1,479 shares worth $478K. The position accounts for 0.06% of the portfolio, ranked #279.
Moloney Securities Asset Management first reported a position in ELV in Q2 2020 and has held it in 22 quarters since. The position peaked at $1.81M in Q4 2022. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.
- Moloney Securities Asset Management held 1,479 shares of Elevance Health worth $478K as of Q3 2025.
- Moloney Securities Asset Management sold 22 Elevance Health shares in Q3 2025, an estimated $6.84K.
- Elevance Health made up 0.06% of Moloney Securities Asset Management's portfolio in Q3 2025, its #279 holding.
- Moloney Securities Asset Management first reported a position in Elevance Health in Q2 2020 and has held it in 22 quarters since.
- Moloney Securities Asset Management's Elevance Health position peaked at $1.81M in Q4 2022.
- 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.
Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.